Burkina Faso vs China: Treatment success rate for patients treated for MDR-TB
Burkina Faso
69.0%
in 2022
China
68.0%
in 2022
Burkina Faso rank
101st
China rank
104th
Treatment success rate for patients treated for MDR-TB over time
- Burkina Faso
- China
How they compare
Burkina Faso currently reports 69.0% against 68.0% in China, a difference of 1.0%.
The two have swapped places 2 times across 15 shared years of data; in 2008 it was Burkina Faso ahead.
Burkina Faso ranks 101st and China ranks 104th of 163 countries.
Burkina Faso has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burkina Faso | China | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 62.5% | 46.0% | 16.5% | Burkina Faso |
| 2010s | 65.3% | 48.4% | 16.9% | Burkina Faso |
| 2020s | 68.0% | 61.7% | 6.3% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Burkina Faso or China?
- Burkina Faso, at 69.0% against 68.0% in China as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Burkina Faso and China?
- 1.0%, with Burkina Faso ahead.
- How many years of comparable data are there for Burkina Faso and China?
- 15 years are reported by both, from 2008 to 2022.
- How do Burkina Faso and China rank globally for treatment success rate for patients treated for mdr-tb?
- Burkina Faso ranks 101st and China ranks 104th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.